Clinical Trial Update: Treatment of Steroid Dependent Idiopathic Nephrotic Syndrome in Children With Low Doses of Interleukin 2: a Pilot Study [Phase 2]

View source ↗

Summary

A Phase 2 pilot study testing low-dose interleukin-2 for steroid-dependent nephrotic syndrome in children has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome
• Steroid-dependent Nephrotic Syndrome

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: University Hospital, Limoges | Conditions: Nephrotic Syndrome Steroid-Dependent, Interleukin 2 | Phase 2 | Status: WITHDRAWN